ClearPoint Neuro, Inc. (CLPT) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.
The consensus price target is $18.00 (low: $9.00, high: $30.00), representing an upside of 73.4% from the current price $10.38.
Analysts estimate Earnings Per Share (EPS) of $-0.67 and revenue of $0.03B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.70 vs est $-0.67 (missed -4.2%). 2025: actual $-0.90 vs est $-0.83 (missed -8.4%). Analyst accuracy: 94%.
CLPT Stock — 12-Month Price Forecast
$18.00
▲ +73.41% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for ClearPoint Neuro, Inc., the average price target is $18.00, with a high forecast of $30.00, and a low forecast of $9.00.
The average price target represents a +73.41% change from the last price of $10.38.
Highest Price Target
$30.00
Average Price Target
$18.00
Lowest Price Target
$9.00
CLPT Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to ClearPoint Neuro, Inc. in the past 3 months
EPS Estimates — CLPT
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.70
vs Est –$0.67
▼ 4.0% off
2025
Actual –$0.90
vs Est –$0.83
▼ 7.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — CLPT
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.031B
vs Est $0.032B
▼ 1.4% off
2025
Actual $0.037B
vs Est $0.037B
▲ 1.0% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
